24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Diabetes
Resources
Basic InformationLatest News
Lost Pregnancies, Diabetes May Be LinkedType 2 Diabetes Linked to Worse Mental Outcomes After StrokeSleep Apnea Tied to Raised Diabetes Risk in Black AmericansHeart Attacks, Strokes Are Declining Among People With DiabetesCould Your Contact Lenses Track, Treat Your Diabetes?AHA News: Managing Diabetes Risk in Hispanic, Asian CommunitiesObesity Is Biggest Type 2 Diabetes Risk FactorAHA News: Understanding the Risky Combination of Diabetes and the CoronavirusWhy Is Coronavirus a Bigger Worry for People With Diabetes?What People With Type 1 Diabetes Need to Know About COVID-19Family Ties Help Young Adults With Type 1 Diabetes FlourishPatch Pump Device Could Offer Cheaper Insulin DeliveryCan AI Predict Who Will Develop Diabetes?Blood Sugar Control May Aid Stroke Recovery in Diabetes PatientsBacteria May Be a Player in Diabetes Among Very ObeseNew Tool Helps Muslims With Diabetes Manage Blood Sugar During Ramadan FastWant to Help Keep Diabetes at Bay? Brush & FlossDiabetes Among U.S. Young, Especially Asians, Continues to ClimbDrug Duo Speeds Regeneration of Key Cells Lost in DiabetesMedicare Could Save Billions If Allowed to Negotiate Insulin PricesAt the Barbershop, a Trim -- and a Diabetes ScreeningCertain Diabetes Meds May Lower Gout Risk, TooBig Advances Made Against Diabetes in 2019CDC Study Breaks Down Diabetes Risk for Hispanic, Asian SubgroupsFDA Authorizes Marketing of Automated Insulin Dosing ControllerDo Processed Foods Up Your Type 2 Diabetes Risk?Changing Timing, Frequency of Meals May Help With Diabetes'Diabetes Burnout' Is Real, Here's How to CopeAs Diabetes Costs Soar, Many Turn to Black Market for HelpFDA Testing Levels of Carcinogen in Diabetes Drug MetforminMom-to-Be's Diabetes May Up Odds of Heart Disease in Her KidsPrediabetes Now Common Among Teens, Young AdultsHeart Attack at 44 Helped Her Realize Diabetes' DangersDiabetes Tougher on Women's HeartsDiabetes Technology Often Priced Out of ReachSupplements Don't Prevent Kidney Disease in Type 2 DiabeticsWhy Are Insulin Prices Still So High for U.S. Patients?Health Tip: Snacks for People With DiabetesHigh-Tech Pacifier Might Monitor Baby's Blood SugarThe Exercise Effect and PrediabetesNext-Gen Artificial Pancreas Boosts Blood Sugar ControlHurricanes Raise Death Risk for Older Diabetics, Even Years LaterYou've Lost the Weight -- Now Keep It Off to Keep Diabetes at BayCould a Pill Replace Insulin Shots?High-Fiber Diet Tied to Lower Heart Risk in Diabetes PatientsJust a Little Weight Loss Can Put Diabetes Into RemissionAffordable Care Act Insured Millions of Uninsured DiabeticsOlder Diabetics May Be Getting Too Much InsulinIt Takes Less Weight to Trigger Diabetes in Minorities Than WhitesFDA OKs New Pill for Type 2 Diabetes
Links
Related Topics

Medical Disorders

FDA Testing Levels of Carcinogen in Diabetes Drug Metformin

HealthDay News
by -- Robert Preidt
Updated: Dec 6th 2019

new article illustration

FRIDAY, Dec. 6, 2019 (HealthDay News) -- Levels of possible cancer-causing chemicals in metformin diabetes medications are under investigation by the U.S. Food and Drug Administration.

Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes.

Over the past year and a half, several types of drugs -- including angiotensin II receptor blockers (ARBs) used for high blood pressure and ranitidine (Zantac) for heartburn -- have been found to contain small amounts of genotoxic substances called nitrosamines, such as N-nitrosodimethylamine (NDMA). A genotoxic substance is something that harms the genetic material in a cell.

Exposure to genotoxic substances above acceptable levels over long periods may increase the risk of cancer, the FDA said.

The FDA has been investigating the presence of nitrosamines in other drug products, and some metformin diabetes medicines in other countries were reported to have low levels of NDMA, according to Dr. Janet Woodcock, director of FDA's Center for Drug Evaluation and Research.

But NDMA levels in metformin drugs abroad are within the range that naturally occurs in some foods and in water, she noted.

Nonetheless, regulators in some other countries are recalling certain metformin drugs, Woodcock said. No metformin recalls affect the U.S. market at the moment.

Woodcock said the FDA is investigating whether metformin in the United States contains NDMA, and whether it exceeds the acceptable daily limit of 96 nanograms.

"The agency will also work with companies to test samples of metformin sold in the U.S. and will recommend recalls as appropriate if high levels of NDMA are found," Woodcock said in an agency statement.

She cited several reasons why impurities can be present in drugs, including manufacturing processes or even the conditions in which they are packaged or stored.

"If as part of our investigation, metformin drugs are recalled, the FDA will provide timely updates to patients and health care professionals," Woodcock said.

Meanwhile, patients who have been prescribed metformin should continue taking it to keep their diabetes under control, she said.

"It could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professional," Woodcock added.

During the investigation, the FDA recommends clinicians continue to use metformin when appropriate because no alternative medications treat the condition in the same way, Woodcock said.

More information

The U.S. Agency for Toxic Substances and Disease Registry has more on NDMA.